JMS logo

Japanese

JMS logo

  1. HOME
  2. Investor Relations
  3. Management Policy
  4. Directors and Auditors

Management Policy

Directors and Auditors(June 22, 2022)

Directors

Hiroaki Okukubo, President and Representative Director

open

Biography / Reason for Appointment
April 1978 Joined the Company
July 2000 Head of President Office
June 2001 Executive Officer
June 2005 Director, Deputy Head of Business Administrative Division
June 2007 Executive Director, Business Administrative Division
June 2011 President and Representative Director (present)

<Reason for appointment>

Mr. Hiroaki Okukubo has abundant work experience in sales, administration and international business at the Company. Since June 2011, he has led the Company’s operations and business activities as President and Representative Director, thereby contributing to enhancement of the Company’s corporate value. We believe he will continue to leverage his experience and knowledge and exert his leadership to facilitate strategic and agile decision-making of the Board of Directors and further promote the growth of the JMS Group.

Yasuhiro Awane,Senior Executive Director
Surgical & Therapeutical Business Unit and Sales and Marketing Division

open

Biography / Reason for Appointment
April 1984 Joined the Company
April 2010 Head of Sales Promotion Division
June 2011 Director, Sales and Marketing Division
June 2013 Director in charge of sales and marketing
June 2015 Executive Director
April 2017 Head of Surgical & Therapeutical Business Unit (present), Head of Sales and Marketing Division (present)
June 2021 Senior Executive Director (present)

<Reason for appointment>

Mr. Yasuhiro Awane has abundant work experience in sales at the Company and in-depth knowledge in marketing. Since June 2011, he has been involved in the management of the Company as a Director while leading the sales division, thereby contributing to enhancement of the Company’s corporate value. We believe he will continue to leverage his experience and knowledge to facilitate strategic and agile decision-making of the Board of Directors and further promote the growth of the JMS Group.

Ryuji Katsura, Executive Director
Corporate Affairs Division and Global Marketing Division

open

Biography / Reason for Appointment
April 1988 Joined the Company
July 2007 General Manager of Finance Department
July 2010 General Manager of Corporate Planning Department
July 2011 Executive Officer
June 2013 Director in charge of corporate planning
April 2017 Head of Corporate Planning Division
July 2019 Head of Global Marketing Division (present)
April 2021 Head of Corporate Affairs Division(present)
June 2021 Executive Director (present)

<Reason for appointment>

Mr. Ryuji Katsura has abundant work experience in planning, finance and international business at the Company. Since June 2013, he has been involved in the management of the Company as a Director while leading the corporate planning division, thereby contributing to enhancement of the Company’s corporate value. We believe he will continue to leverage his experience and knowledge to facilitate strategic and agile decision-making of the Board of Directors and further promote the growth of the JMS Group.

Masafumi Sato, Director
Hospital Products Business Unit and Research and Development Division

open

Biography / Reason for Appointment
April 1987 Joined the Company
July 2009 General Manager of Technology Development Department, Izumo Plant
July 2011 Executive Officer, Research and Development Division
June 2013 Director (present) in charge of research and development, Research and Development Division
April 2017 Head of Hospital Products Business Unit (present), Head of Research and Development Division (present)

<Reason for appointment>

Mr. Masafumi Sato has abundant work experience in research and development as well as production at the Company. Since June 2013, he has been involved in the management of the Company as a Director while leading the research and development division, thereby contributing to enhancement of the Company’s corporate value. We believe he will continue to leverage his experience and knowledge to facilitate strategic and agile decision-making of the Board of Directors and further promote the growth of the JMS Group.

Shogo Yanagida, Director
Blood Management & Cell Therapy Business Unit and Production Division

open

Biography / Reason for Appointment
April 1986 Joined the Company
November 2011 General Manager of Technology Development Department, Izumo Plant
July 2013 Executive Officer, Miyoshi Plant Manager
June 2017 Director (present), Deputy Head of Production Division
June 2019 Head of Production Division (present)
April 2020 Head of Blood Management & Cell Therapy Business Unit (present)

<Reason for appointment>

Mr. Shogo Yanagida has abundant work experience in production as well as research and development at the Company. Since June 2017, he has been involved in the management of the Company as Director while leading the production division, thereby contributing to enhancement of the Company’s corporate value. We believe he will continue to leverage his experience and knowledge to facilitate strategic and agile decision-making of the Board of Directors and further promote the growth of the JMS Group.

Kazuo Ikemura, Director (Outside)

open

Biography / Reason for Appointment
April 1983 Registered as a lawyer (Hiroshima Bar Association)
June 1983 Joined Tomikawa Law Office
August 1991 Established Hiroshima Central Law Office (present)
June 2011 Audit & Supervisory Board Member of the Company
June 2015 Director of the Company (present)
June 2020 Outside Auditor of Fukutome Meat Packers, Ltd. (present)

<Reason for appointment>

Although Mr. Kazuo Ikemura has not been involved in corporate management in the past, he is familiar with the Company’s businesses because he has served as an outside officer of the Company since June 2011. In addition, he has abundant professional knowledge and experience as a lawyer. As we believe he can play an appropriate role in managerial decision-making and supervision of the business execution of the JMS Group, we appointed him as an Outside Director of the Company.

Shozo Ishizaka, Director (Outside)

open

Biography / Reason for Appointment
April 1985 Joined Kaneka Corporation
June 2010 Director, Head of Vascular Management Group, Sales Management Department, and Head of Asia Office of Kaneka Medix Corporation
April 2017 Executive Vice President of Kaneka Medix Corporation
April 2018 President of Kaneka Medix Corporation (present)
June 2019 Director of the Company (present)

<Reason for appointment>

Mr. Shozo Ishizaka has a substantial track record and knowledge in the medical device industry. As we believe he can play an appropriate role in managerial decision-making and supervision of the business execution of the JMS Group, we appointed him as an Outside Director of the Company.

Auditors

Yoshio Kondo, Standing Audit & Supervisory Board Member

open

Biography / Reason for Appointment
April 1980 Joined the Company
June 2002 General Manager of Purchasing Department
July 2005 Head of International Business Division
July 2011 President and Representative Director, JMS SINGAPORE PTE. LTD.
June 2015 General Manager of Finance Department
June 2018 Standing Audit & Supervisory Board Member (present)

<Reason for appointment>

Mr. Yoshio Kondo has abundant work experience in administration at the Company. In addition, he has served as president of an overseas subsidiary. He has been appointed as an Audit & Supervisory Board Member with the expectation that he will leverage his experience and knowledge for audit and supervision of the Company’s corporate management.

Akira Mito, Audit & Supervisory Board Member (Outside)

open

Biography / Reason for Appointment
July 2013 Resigned from District Director of Okayama West Tax Office
August 2013 Established Mito Tax Accountant Office (present)
June 2015 Substitute Audit & Supervisory Board Member of the Company
June 2016 Audit & Supervisory Board Member of the Company (present)

<Reason for appointment>

Although Mr. Akira Mito has not been involved in corporate management in the past, he has been appointed as an Audit & Supervisory Board Member with the expectation that he will leverage his professional knowledge and experience as a tax accountant for audit and supervision of the Company’s corporate management.

Yoshiharu Sagami, Audit & Supervisory Board Member (Outside)

open

Biography / Reason for Appointment
April 1981 Joined Asahi & Co. (present KPMG AZSA LLC)
June 2010 Resigned from KPMG AZSA LLC
July 2010 Established Sagami CPA Office (present)
June 2015 Outside Director and Audit Committee Member of Br. Holdings Corporation (present)
June 2021 Audit & Supervisory Board Member of the Company (present)

<Reason for appointment>

Although Mr. Yoshiharu Sagami has not been involved in corporate management other than as an outside officer at other company, he has been appointed as an Audit & Supervisory Board Member with the expectation that he will leverage his professional knowledge and experience as a certified public accountant for audit and supervision of the Company’s corporate management.